UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000060176
Receipt number R000068822
Scientific Title A Study on the Efficacy and Safety of Minocycline and Sitafloxacin for Non-gonococcal Urethritis in Men
Date of disclosure of the study information 2025/12/23
Last modified on 2025/12/23 11:26:49

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A Study on the Efficacy and Safety of Minocycline and Sitafloxacin for Non-gonococcal Urethritis in Men

Acronym

A Study on the Efficacy and Safety of Minocycline and Sitafloxacin for Non-gonococcal Urethritis in Men

Scientific Title

A Study on the Efficacy and Safety of Minocycline and Sitafloxacin for Non-gonococcal Urethritis in Men

Scientific Title:Acronym

A Study on the Efficacy and Safety of Minocycline and Sitafloxacin for Non-gonococcal Urethritis in Men

Region

Japan


Condition

Condition

Non-gonococcal Urethritis

Classification by specialty

Urology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

A Study on the Efficacy and Safety of Minocycline and Sitafloxacin for Non-gonococcal Urethritis in Men

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Efficacy and Safety 21 to 28 Days After Initiation of Minocycline Treatment

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Patients with non-gonococcal urethritis should receive minocycline 100 mg orally twice daily for 7 days. If testing at the start of minocycline therapy is positive for M. genitalium, sitafloxacin 100 mg should be added orally twice daily for an additional 7 days.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

16 years-old <=

Age-upper limit


Not applicable

Gender

Male

Key inclusion criteria

Symptoms: Patients presenting with symptoms of non-gonococcal urethritis.
Pyuria: Cases meeting any of the following criteria for pyuria prior to initiation of medication.
Using non-centrifuged urine with a designated device: >=10 WBCs/uL
Using non-centrifuged urine with a urine test strip method (based on esterase activity measurement): Positive
Urinalysis sediment microscopy: >=5 WBCs/hpf

Key exclusion criteria

1) Patients who received other antimicrobial agents prior to study drug initiation and whose symptoms were already improving
2) Patients who received tetracycline-class antimicrobial agents within one week prior to study drug initiation
3) Patients with severe underlying diseases or complications that would make it difficult to evaluate the efficacy and safety of the study drug
4) Patients with a history of allergy to tetracycline-class antimicrobial agents
5) Patients with severe cardiac dysfunction or hepatic dysfunction
6) Patients with moderate or greater renal impairment (serum creatinine >= 2 mg/dL as a guideline)
7) Other patients deemed unsuitable by the attending physician

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Mitsuru
Middle name
Last name Yasuda

Organization

Sapporo Medical University School of Medicine

Division name

Department of Infection Control & Laboratory Medicine

Zip code

060-8543

Address

S1 W16,Chuo-ku,Sapporo,060-8543,JAPAN

TEL

+81-11-611-2111

Email

yasuda7jpe@sapmed.ac.jp


Public contact

Name of contact person

1st name Mitsuru
Middle name
Last name Yasuda

Organization

Sapporo Medical University School of Medicine

Division name

Department of Infection Control & Laboratory Medicine

Zip code

060-8543

Address

S1 W16,Chuo-ku,Sapporo,060-8543,JAPAN

TEL

+81-11-611-2111

Homepage URL


Email

yasuda7jpe@sapmed.ac.jp


Sponsor or person

Institute

Sapporo Medical University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Japan Agency for Medical Research and Development

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Sapporo Medical University Hospital Institutional Review Board

Address

S1 W16,Chuo-ku,Sapporo,060-8543,JAPAN

Tel

+81-11-611-2111

Email

ji-rskk@ml.sapmed.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 12 Month 23 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2023 Year 05 Month 22 Day

Date of IRB

2024 Year 01 Month 11 Day

Anticipated trial start date

2024 Year 01 Month 11 Day

Last follow-up date

2027 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2025 Year 12 Month 23 Day

Last modified on

2025 Year 12 Month 23 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000068822